Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

First-trimester cystic hygroma and omphalocele in a fetus with Turner syndrome.

Chen CP, Chang SY, Lau HS, Chen SW, Lai ST, Chuang TY, Lee MS, Wang W.

Taiwan J Obstet Gynecol. 2018 Oct;57(5):763-764. doi: 10.1016/j.tjog.2018.08.030. No abstract available.

2.

Qualitative Evaluation of the Coach Training within a Community Paramedicine Care Transitions Intervention.

Lau HS, Hollander MM, Cushman JT, DuGoff EH, Jones CMC, Kind AJH, Lohmeier MT, Coleman EA, Shah MN.

Prehosp Emerg Care. 2018 Jul-Aug;22(4):527-534. doi: 10.1080/10903127.2017.1419325. Epub 2018 Feb 12.

PMID:
29432041
3.

[Poisoning with organophosphate compounds].

Vos EM, Hens JJ, Lau HS, Boon ES, Bartelink AK.

Ned Tijdschr Geneeskd. 2002 Jan 5;146(1):34-7. Dutch.

PMID:
11802337
4.
5.

A nation-wide study on the practice of euthanasia and physician-assisted suicide in community and hospital pharmacies in The Netherlands.

Lau HS, Riezebos J, Abas V, Porsius AJ, De Boer A.

Pharm World Sci. 2000 Feb;22(1):3-9.

PMID:
10815293
6.

Validation of pharmacy records in drug exposure assessment.

Lau HS, de Boer A, Beuning KS, Porsius A.

J Clin Epidemiol. 1997 May;50(5):619-25.

PMID:
9180655
7.

Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function.

Berenson JR, Rosen L, Vescio R, Lau HS, Woo M, Sioufi A, Kowalski MO, Knight RD, Seaman JJ.

J Clin Pharmacol. 1997 Apr;37(4):285-90.

PMID:
9115053
8.

Selective decontamination of the digestive tract: effect of cessation of routine application at an ICU.

Tissot van Patot HA, Leusink JA, Roodenburg J, de Jongh BM, Lau HS, de Boer S, de Boer A.

Pharm World Sci. 1996 Oct;18(5):171-7.

PMID:
8933577
9.

Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis.

Lau HS, Beuning KS, Postma-Lim E, Klein-Beernink L, de Boer A, Porsius AJ.

Pharm World Sci. 1996 Apr;18(2):63-8.

PMID:
8739259
10.

Analysis of diclofenac and four of its metabolites in human urine by HPLC.

Sawchuk RJ, Maloney JA, Cartier LL, Rackley RJ, Chan KK, Lau HS.

Pharm Res. 1995 May;12(5):756-62.

PMID:
7479564
11.

Absorption of flurbiprofen in the fed and fasted states.

Dressman JB, Berardi RR, Elta GH, Gray TM, Montgomery PA, Lau HS, Pelekoudas KL, Szpunar GJ, Wagner JG.

Pharm Res. 1992 Jul;9(7):901-7.

12.
13.

Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with chronic renal failure.

Lau HS, Hyneck ML, Berardi RR, Swartz RD, Smith DE.

Clin Pharmacol Ther. 1986 Jun;39(6):635-45.

14.

Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.

Nakagawa Y, Abram V, Parks JH, Lau HS, Kawooya JK, Coe FL.

J Clin Invest. 1985 Oct;76(4):1455-62.

15.

Determinants of bumetanide response in the dog: effect of indomethacin.

Smith DE, Lau HS.

J Pharm Sci. 1983 Nov;72(11):1298-302.

PMID:
6644592
16.

Effect of probenecid on the dose-response relationship of bumetanide at steady state.

Lau HS, Shih LJ, Smith DE.

J Pharmacol Exp Ther. 1983 Oct;227(1):51-4.

PMID:
6620171
17.

Application of effect-compartment model to bumetanide-indomethacin interaction in dogs.

Smith DE, Lau HS, Fox JL.

J Pharmacokinet Biopharm. 1983 Aug;11(4):355-68.

18.

Determinants of bumetanide response in the dog: effect of probenecid.

Smith DE, Lau HS.

J Pharmacokinet Biopharm. 1983 Feb;11(1):31-46.

19.

Role of sugars in human neutrophilic phagocytosis.

Sanchez A, Reeser JL, Lau HS, Yahiku PY, Willard RE, McMillan PJ, Cho SY, Magie AR, Register UD.

Am J Clin Nutr. 1973 Nov;26(11):1180-4. No abstract available.

PMID:
4748178
20.

Evaluation of media and methods for chlamydospore formation by Candida albicans.

Lau HS.

Tech Bull Regist Med Technol. 1968 Jun;38(6):158-60. No abstract available.

PMID:
5677103
21.
22.

Candida albicans in acute pneumonitis following surgery.

Lau HS, Reiber CD, Dale CL.

Antimicrob Agents Chemother (Bethesda). 1967;7:173-7. No abstract available.

PMID:
5596138
23.

Supplemental Content

Support Center